Adjudicatario
LFB BIOMEDICAMENTS
LES ULIS · FRA
Seguir este registroCuenta gratuita: reciba un aviso cuando un contrato aquí venza.
Adjudicaciones
23
Importe total adjudicado
1101,2 M €
2 adjudicación(es) conjunta(s) contada(s) a prorrata
Órganos de contratación
6
Sectores
1
Grupo: LFB BIOMEDICAMENTS
Reg. 491 371 167 00017
Contratos de este adjudicatario próximos a vencer
- 31 jul 2027declaradaAbschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der LFB Biomedicaments zu Willfact und CevenfactaIKK classicLFB BIOMEDICAMENTS1 €
- 30 abr 2029declaradaJ06BA02 - IG HUMAINES POLYVALENTES IV 10% PRETES A L'EMPLOI - STABILISE A LA GLYCINE + POLYSORBATEGIP RESAHLFB BIOMEDICAMENTS356.580 €
- 31 may 2029declaradaFACTEUR VIII HUMAIN PLASMATIQUEHospices Civils de LyonLFB BIOMEDICAMENTS23.849.005 €
- 31 may 2029declaradaFACTEUR IX HUMAIN PLASMATIQUE sécurisation virale SD et nanofiltration à 15 nmHospices Civils de LyonLFB BIOMEDICAMENTS5.178.670 €
- 31 may 2029declaradaALBUMINE HUMAINE 200MG / ML (20%)Hospices Civils de LyonLFB BIOMEDICAMENTS12.956.735 €
- 31 may 2029declaradaALBUMINE HUMAINE 200MG / ML (20%)Hospices Civils de LyonLFB BIOMEDICAMENTS11.501.659 €
- 31 may 2029declaradaALBUMINE HUMAINE 200MG / ML (20%)Hospices Civils de LyonLFB BIOMEDICAMENTS10.859.806 €
- 31 may 2029declaradaALBUMINE HUMAINE 40MG / ML (4%)Hospices Civils de LyonLFB BIOMEDICAMENTS11.484.167 €
- 31 may 2029declaradaALBUMINE HUMAINE 50MG / ML (5%)Hospices Civils de LyonLFB BIOMEDICAMENTS3.380.883 €
- 31 may 2029declaradaALPHA-1 ANTITRYPSINE D'ORIGINE HUMAINE 33.33 MG / MLHospices Civils de LyonLFB BIOMEDICAMENTS37.930.100 €
- 31 may 2029declaradaFIBRINOGENE HUMAINHospices Civils de LyonLFB BIOMEDICAMENTS, OCTAPHARMA FRANCE69.652.461 €
- 31 may 2029declaradaFACTEUR WILLEBRAND HUMAIN 100 UI / ML PURHospices Civils de LyonLFB BIOMEDICAMENTS58.157.024 €
- 31 may 2029declaradaFACTEUR XI HUMAINHospices Civils de LyonLFB BIOMEDICAMENTS460.257.600 €
- 31 may 2029declaradaIG ANTITETANIQUE HUMAIN 250 UI / 2 MLHospices Civils de LyonLFB BIOMEDICAMENTS2.029.551 €
- 31 may 2029declaradaIG SPECIFIQUES ANTI HEPATITE B 100 UI / 1 MLHospices Civils de LyonLFB BIOMEDICAMENTS2.125.200 €
- 31 may 2029declaradaIG SPECIFIQUES ANTI HEPATITE B 500 UI / 5 MLHospices Civils de LyonLFB BIOMEDICAMENTS1.914.000 €
- 31 may 2029declaradaIG SPECIFIQUES ANTI HEPATITE B HUMAINE 5000 UI / 100 ML IVHospices Civils de LyonLFB BIOMEDICAMENTS14.491.404 €
- 31 may 2029declaradaIG POLYVALENTE HUMAINE IV 50MG / ML (5%) PAE - teneur en Ig A < 0.022 mg / mlHospices Civils de LyonLFB BIOMEDICAMENTS304.767.612 €
- 31 may 2029declaradaIG POLYVALENTE HUMAINE IV 50 MG/ML (5%) LYOPHILISEHospices Civils de LyonLFB BIOMEDICAMENTS56.145.276 €
Todos los contratos próximos a vencer →